Published in Cancer on April 15, 1997
Central venous port systems as an integral part of chemotherapy. Dtsch Arztebl Int (2011) 2.99
Complete caval thrombosis secondary to an implanted venous port--a case study. Dtsch Arztebl Int (2008) 1.42
Catheter tip position as a risk factor for thrombosis associated with the use of subcutaneous infusion ports. Support Care Cancer (2004) 1.23
Central venous access: techniques and indications in oncology. Eur Radiol (2008) 1.02
Long-term outcome of radiological-guided insertion of implanted central venous access port devices (CVAPD) for the delivery of chemotherapy in cancer patients: institutional experience and review of the literature. Br J Cancer (2004) 1.02
Totally implantable venous access devices: retrospective analysis of different insertion techniques and predictors of complications in 796 devices implanted in a single institution. BMC Surg (2014) 0.92
Skin and soft tissue infections in hospitalized and critically ill patients: a nationwide population-based study. BMC Infect Dis (2010) 0.84
Use of totally implantable central venous access port via the basilic vein in patients with thoracic malignancies. Int J Clin Oncol (2009) 0.84
Administration of chemotherapy via the median cubital vein without implantable central venous access ports: port-free chemotherapy for metastatic colorectal cancer patients. Int J Clin Oncol (2014) 0.81
A single institution observational study of early mechanical complications in central venous catheters (valved and open-ended) in children with cancer. Pediatr Surg Int (2004) 0.78
Mechanical Complication with Broviac Repair Kit in a 4-Year-Old Boy with MEN 2a. Int J Pediatr (2009) 0.75
Femoral Placement of Totally Implantable Venous Access Ports in Patients with Bilateral Breast Cancer. Geburtshilfe Frauenheilkd (2016) 0.75
A Study of Use of "PORT" Catheter in Patients with Cancer: A Single-Center Experience. Clin Med Insights Oncol (2017) 0.75
The duration of functioning of a subcutaneous implantable port for the treatment of hematological tumors: a single institution-based study. Int J Clin Oncol (2010) 0.75
Morbidity-mortality conference for adverse events associated with totally implanted venous access for cancer chemotherapy. Support Care Cancer (2015) 0.75
Central venous port implantations via the cephalic vein applying an intravasal electrographic control of the catheter tip position: a single-center experience of 316 cases. World J Urol (2011) 0.75
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol (2001) 10.20
Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol (2001) 9.68
Liver resection for colorectal metastases. J Clin Oncol (1997) 4.88
Radical surgery for gastric cancer. A review of the Japanese experience. Cancer (1989) 2.91
Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients. Ann Surg (1993) 2.87
Alpha-factor-directed synthesis and secretion of mature foreign proteins in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1984) 2.74
Surgery for melanoma metastatic to the gastrointestinal tract. Ann Surg Oncol (1999) 2.61
Prospective randomized clinical trial of the value of intraperitoneal drainage after pancreatic resection. Ann Surg (2001) 2.47
Metastatic breast cancer masquerading as gastrointestinal primary. Am J Gastroenterol (1998) 2.33
Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg (1998) 2.32
Improved staging of node-negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy. Ann Surg Oncol (2001) 2.19
Management of primary and recurrent soft-tissue sarcoma of the retroperitoneum. Ann Surg (1990) 2.17
The role of surgery in the treatment of clinically isolated adrenal metastasis. Cancer (1998) 1.97
Patterns of detection in patients with cutaneous melanoma. Cancer (2000) 1.97
Merkel cell carcinoma. Prognosis and management. Arch Surg (1991) 1.72
A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer (2000) 1.52
The prognostic impact of isolated tumor cells in lymph nodes of T2N0 gastric cancer: comparison of American and Japanese gastric cancer patients. Ann Surg Oncol (2009) 1.50
The value of minimal access surgery in the staging of patients with potentially resectable peripancreatic malignancy. Ann Surg (1996) 1.50
Surgical oncology fellowship: viable pathway to academic surgery? Ann Surg Oncol (1999) 1.46
Is intra-abdominal drainage necessary after pancreaticoduodenectomy? J Gastrointest Surg (1999) 1.45
Detection of tyrosinase mRNA by reverse transcription-polymerase chain reaction in melanoma sentinel nodes. Ann Surg Oncol (1999) 1.44
The malignant nature of papillary and cystic neoplasm of the pancreas. Cancer (1991) 1.42
Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence. Ann Surg (2001) 1.36
Desmoplastic small round cell tumors: prognostic indicators and results of surgical management. Ann Surg Oncol (1998) 1.35
Does the extent of operation influence the prognosis in patients with melanoma metastatic to inguinal nodes? Ann Surg Oncol (1999) 1.26
Melanoma metastatic to stomach, small bowel, or colon. Am J Surg (1991) 1.24
Surgical management of Merkel cell carcinoma. Ann Surg (1999) 1.21
Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement. J Clin Oncol (2001) 1.10
High-frequency jet ventilation. A prospective randomized evaluation. Chest (1983) 1.05
Identification of poor prognostic features among patients requiring mechanical ventilation after hematopoietic stem cell transplantation. Blood (2001) 1.03
Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinoma. Br J Cancer (2011) 1.01
Direct observations of surgical wound infections at a comprehensive cancer center. Arch Surg (1995) 1.00
Intraoperative lymphatic mapping and sentinel lymph node biopsy for Merkel cell carcinoma. Br J Surg (1999) 0.98
Hepatic metastases from soft-tissue sarcoma. Ann Surg (1995) 0.96
Immunohistochemical analysis of sentinel lymph nodes from patients with Merkel cell carcinoma. Cancer (2001) 0.95
Major amputation for advanced malignant melanoma. Surg Gynecol Obstet (1989) 0.94
A phase II trial of neoadjuvant cisplatin-fluorouracil followed by postoperative intraperitoneal floxuridine-leucovorin in patients with locally advanced gastric cancer. Ann Oncol (2006) 0.93
Transcutaneously tunneled central venous lines in cancer patients: an analysis of device-related morbidity factors based on prospective data collection. Ann Surg Oncol (2000) 0.91
Axillary dissection in melanoma. Prognostic variables in node-positive patients. Ann Surg (1990) 0.91
The intensive care unit medical director as manager. Impact on performance. Med Care (1995) 0.89
Tidal volume and airway pressure on high frequency jet ventilation. Crit Care Med (1983) 0.88
A prospective analysis of vascular access device-related infections in children. J Pediatr Surg (1992) 0.87
Life-threatening fluid and electrolyte abnormalities associated with cancer. Crit Care Clin (1988) 0.86
Computed tomography in evaluation of patients with stage III melanoma. Ann Surg Oncol (1997) 0.86
Recurrence patterns and outcome in 1019 patients undergoing axillary or inguinal lymphadenectomy for melanoma. Arch Surg (1992) 0.86
Phase I evaluation of a combination of monoclonal antibody R24 and interleukin 2 in patients with metastatic melanoma. Cancer Res (1990) 0.85
Phase II trial of neoadjuvant temozolomide in resectable melanoma patients. Ann Oncol (2010) 0.85
Naloxone in septic shock. Crit Care Med (1983) 0.84
Indications for and efficacy of splenectomy for haematological disorders. Br J Surg (2013) 0.83
Melanoma. A multidisciplinary approach for the general surgeon. Surg Clin North Am (2000) 0.82
Prognosis of thick cutaneous melanoma. J Am Coll Surg (1999) 0.81
Role of elective lymph node dissection in melanoma. Semin Surg Oncol (1998) 0.81
Association of positive transection margins with gastric cancer survival and local recurrence. Ann Surg Oncol (2013) 0.80
Capnography in mechanically ventilated patients. Crit Care Med (1988) 0.80
Early recurrence after lymphatic mapping and sentinel node biopsy in patients with primary extremity melanoma: a comparison with elective lymph node dissection. Ann Surg Oncol (2001) 0.80
Sentinel lymph node evaluation in melanoma. Arch Dermatol (1997) 0.79
Relationship between glucose oxidation and FFA concentration in septic cancer-bearing patients. Metabolism (1988) 0.79
Free fatty acid turnover and lipolysis in septic mechanically ventilated cancer-bearing humans. Metabolism (1988) 0.79
Long-term vascular access via the inferior vena cava. J Surg Oncol (1991) 0.78
Focal nodular hyperplasia of the liver. Surg Gynecol Obstet (1990) 0.78
High-dose naloxone: pharmacokinetics in patients in septic shock. Crit Care Med (1987) 0.78
Bronchobiliary fistula complicating oriental cholangiohepatitis. HPB (Oxford) (2002) 0.78
Preoperative chemotherapy does not influence the number of evaluable lymph nodes in resected gastric cancer. Eur J Surg Oncol (2012) 0.78
Staging work-up and post-treatment surveillance of patients with melanoma. Clin Plast Surg (2000) 0.77
Reverse transcriptase polymerase chain reaction (RT-PCR) detection of melanoma-related transcripts in the peripheral blood and bone marrow of patients with malignant melanoma. What have we learned? Recent Results Cancer Res (2001) 0.77
Peritoneovenous shunting for nongynecologic malignant ascites. Cancer (2001) 0.77
Acute complications of central line placement in profoundly thrombocytopenic cancer patients. Cancer (1996) 0.77
Flow triggering added to pressure support ventilation improves comfort and reduces work of breathing in mechanically ventilated patients. J Crit Care (1999) 0.76
Merkel cell carcinoma. Aust N Z J Surg (1999) 0.76
Circulatory shock. Crit Care Clin (2001) 0.75
Physiologic implications of high frequency jet ventilation techniques. Crit Care Med (1983) 0.75
The "true" sentinel lymph node: in search of an operational definition of a biological phenomenon. Ann Surg Oncol (2001) 0.75
Endogenous opioids and hypoxic survival. Crit Care Med (1999) 0.75
Association between molecular detection of GAGE and survival in patients with malignant melanoma: a retrospective cohort study. Clin Cancer Res (1999) 0.75
Successful management of CMV pneumonia in a mechanically ventilated patient. Chest (1991) 0.75
Indirect calorimetry in the mechanically ventilated patient. Crit Care Med (1987) 0.75
Experimental evaluation of high-frequency jet ventilation. Crit Care Med (1984) 0.75
The effect of varying inspiratory flow waveforms on pulmonary mechanics in critically ill patients. J Crit Care (2000) 0.75
Ventilation at supraphysiologic frequencies. Theoretical, technical, experimental, and clinical basis. Acute Care (1986) 0.75
High-frequency jet ventilation: technical implications. Crit Care Med (1984) 0.75
Prostaglandin therapy in a case of refractory stress ulcer bleeding. Crit Care Med (1982) 0.75
High frequency jet ventilation in experimental airway disruption. Crit Care Med (1983) 0.75
The response of fibronectin to differing parenteral caloric sources in normal man. JPEN J Parenter Enteral Nutr (1985) 0.75
Opioid antagonists in circulatory shock. Crit Care Med (1986) 0.75
Safe and cost effective use of alteplase for the clearance of occluded central venous access devices. J Clin Oncol (2002) 0.75
Adjuvant therapy of malignant melanoma. Surg Oncol Clin N Am (1997) 0.75
Early prediction of outcome of respiratory failure. Comparison of high-frequency jet ventilation and volume-cycled ventilation. Chest (1984) 0.75
ECG infusion artifact. Chest (1984) 0.75
Lymphatic mapping in the management of melanoma in children. Pediatr Dermatol (1999) 0.75
Role of high-frequency jet ventilation in the management of respiratory failure. Crit Care Med (1984) 0.75
Cetacaine-induced acute methemoglobinemia. Anesthesiology (1988) 0.75